Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Head and Neck Cancer

  Free Subscription


21.10.2019

6 Ann Otol Rhinol Laryngol
1 Ann Surg
2 Ann Thorac Surg
1 BMC Surg
1 Br J Cancer
2 Br J Oral Maxillofac Surg
1 Cancer
1 Clin Cancer Res
2 Clin Nucl Med
3 Dis Esophagus
1 Head Neck
1 HNO
2 Int J Cancer
2 J Clin Oncol
2 Laryngoscope
1 Otolaryngol Head Neck Surg
13 Surgery


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Otol Rhinol Laryngol

  1. DOODY J, Adil EA, Trenor CC 3rd, Cunningham MJ, et al
    The Genetic and Molecular Determinants of Juvenile Nasopharyngeal Angiofibroma: A Systematic Review.
    Ann Otol Rhinol Laryngol. 2019;128:1061-1072.
    PubMed     Text format     Abstract available

  2. REID J, Wehrli B, Sowerby LJ
    Spindle Cell Lipomas of the Respiratory Tract: A Case Report and Comprehensive Literature Review.
    Ann Otol Rhinol Laryngol. 2019;128:1086-1091.
    PubMed     Text format     Abstract available

  3. EGUCHI K, Chan JYK, Tateya I, Shimizu A, et al
    Curved Laryngopharyngoscope With Flexible Next-Generation Robotic Surgical System for Transoral Hypopharyngeal Surgery: A Preclinical Evaluation.
    Ann Otol Rhinol Laryngol. 2019;128:1023-1029.
    PubMed     Text format     Abstract available

  4. ALZATE AMAYA F, Invencio da Costa LF, Martinez Moran A, Alvarez Rodriguez R, et al
    Unusual Nasal Insufficiency in an Infant: What's Behind the Nostril?
    Ann Otol Rhinol Laryngol. 2019;128:1078-1080.
    PubMed     Text format     Abstract available

  5. WAKASAKI T, Yasumatsu R, Masuda M, Matsuo M, et al
    Small Cell Carcinoma in the Head and Neck.
    Ann Otol Rhinol Laryngol. 2019;128:1006-1012.
    PubMed     Text format     Abstract available

  6. SHARBEL DD, Unsal AA, Groves MW, Albergotti WG, et al
    Salivary Clear Cell Carcinoma Clinicopathologic Characteristics and Outcomes: A Population-Based Analysis.
    Ann Otol Rhinol Laryngol. 2019;128:989-996.
    PubMed     Text format     Abstract available


    Ann Surg

  7. VAN WORKUM F, Stenstra MHBC, Berkelmans GHK, Slaman AE, et al
    Learning Curve and Associated Morbidity of Minimally Invasive Esophagectomy: A Retrospective Multicenter Study.
    Ann Surg. 2019;269:88-94.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  8. KOHTZ PD, Halpern AL, Eldeiry MA, Hazel K, et al
    Toll-Like Receptor-4 Is a Mediator of Proliferation in Esophageal Adenocarcinoma.
    Ann Thorac Surg. 2019;107:233-241.
    PubMed     Text format     Abstract available

  9. NOBEL T, Dave N, Eljalby M, Xing X, et al
    Incidence and Risk Factors for Isolated Esophageal Cancer Recurrence to the Brain.
    Ann Thorac Surg. 2019 Oct 12. pii: S0003-4975(19)31583.
    PubMed     Text format     Abstract available


    BMC Surg

  10. KANDA M, Koike M, Tanaka C, Kobayashi D, et al
    Feasibility of subtotal esophagectomy with systematic lymphadenectomy in selected elderly patients with esophageal cancer; a propensity score matching analysis.
    BMC Surg. 2019;19:143.
    PubMed     Text format     Abstract available


    Br J Cancer

  11. HUTCHISON IL, Ridout F, Cheung SMY, Shah N, et al
    Nationwide randomised trial evaluating elective neck dissection for early stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort.
    Br J Cancer. 2019 Oct 15. pii: 10.1038/s41416-019-0587.
    PubMed     Text format     Abstract available


    Br J Oral Maxillofac Surg

  12. ROGERS SN, Swain A, Carroll C, Lowe D, et al
    Incidence, timing, presentation, treatment, and outcomes of second primary head and neck squamous cell carcinoma after oral cancer.
    Br J Oral Maxillofac Surg. 2019 Oct 11. pii: S0266-4356(19)30387.
    PubMed     Text format     Abstract available

  13. SHETTY SS, Kudpaje A, Rao V, Jayaraj R, et al
    Re: adjuvant radiation in early oral cancers with isolated perineural invasion.
    Br J Oral Maxillofac Surg. 2019 Oct 7. pii: S0266-4356(19)30384.
    PubMed     Text format    


    Cancer

  14. BEESLEY LJ, Hawkins PG, Amlani LM, Bellile EL, et al
    Individualized survival prediction for patients with oropharyngeal cancer in the human papillomavirus era.
    Cancer. 2019;125:68-78.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  15. HE LJ, Xie C, Wang ZX, Li Y, et al
    Submucosal saline injection followed by endoscopic ultrasound versus endoscopic ultrasound only for distinguishing between T1a and T1b esophageal cancer.
    Clin Cancer Res. 2019 Oct 15. pii: 1078-0432.CCR-19-1722.
    PubMed     Text format     Abstract available


    Clin Nucl Med

  16. JEONG E, Yoon JK, Lee SJ, Soh EY, et al
    Risk Factors for Indeterminate Response After Radioactive Iodine Therapy in Patients With Differentiated Thyroid Cancer.
    Clin Nucl Med. 2019 Jun 1. doi: 10.1097/RLU.0000000000002653.
    PubMed     Text format     Abstract available

  17. TRIPATHY S, Aggrawal S, Subudhi K, Kumar R, et al
    Calcitonin-Negative Neuroendocrine Tumor of the Thyroid on 68Ga DOTANOC PET-CT.
    Clin Nucl Med. 2019 Jul 5. doi: 10.1097/RLU.0000000000002698.
    PubMed     Text format     Abstract available


    Dis Esophagus

  18. ROSEIRA J, Mao de Ferro S, Moleiro J, Currais P, et al
    Utility of stent double palliation for esophageal cancer with airway involvement: the extremis of care.
    Dis Esophagus. 2019 Oct 16. pii: 5588491. doi: 10.1093.
    PubMed     Text format     Abstract available

  19. ESAKI M, Hayashi Y, Ikehara H, Ihara E, et al
    The effect of scissor-type versus non-scissor-type knives on the technical outcomes in endoscopic submucosal dissection for superficial esophageal cancer: a multi-center retrospective study.
    Dis Esophagus. 2019 Oct 16. pii: 5588494. doi: 10.1093.
    PubMed     Text format     Abstract available

  20. YANG Y, Zhang X, Li B, Hua R, et al
    Short- and mid-term outcomes of robotic versus thoraco-laparoscopic McKeown esophagectomy for squamous cell esophageal cancer: a propensity score-matched study.
    Dis Esophagus. 2019 Oct 11. pii: 5585597. doi: 10.1093.
    PubMed     Text format     Abstract available


    Head Neck

  21. NG WT, Lee MC, Fung NT, Wong EC, et al
    Dose volume effects of re-irradiation for locally recurrent nasopharyngeal carcinoma.
    Head Neck. 2019 Oct 16. doi: 10.1002/hed.25988.
    PubMed     Text format     Abstract available


    HNO

  22. DOESCHER J, Busch CJ, Wollenberg B, Dietz A, et al
    [Immunotherapy for head and neck cancer : Highlights of the 2019 ASCO Annual Meeting].
    HNO. 2019 Oct 14. pii: 10.1007/s00106-019-00761.
    PubMed     Text format     Abstract available


    Int J Cancer

  23. BECKHAM TH, Barney C, Healy E, Wolfe AR, et al
    Platinum-Based Regimens Versus Cetuximab in Definitive Chemoradiation for Human Papillomavirus-Unrelated Head and Neck Cancer.
    Int J Cancer. 2019 Oct 14. doi: 10.1002/ijc.32736.
    PubMed     Text format     Abstract available

  24. LEONG MML, Cheung AKL, Kwok TCT, Lung ML, et al
    Functional Characterization of a Candidate Tumor Suppressor Gene, Mirror Image Polydactyly 1, in Nasopharyngeal Carcinoma.
    Int J Cancer. 2019 Oct 14. doi: 10.1002/ijc.32732.
    PubMed     Text format     Abstract available


    J Clin Oncol

  25. ARGIRIS A, Li S, Savvides P, Ohr JP, et al
    Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer.
    J Clin Oncol. 2019 Oct 16:JCO1900555. doi: 10.1200/JCO.19.00555.
    PubMed     Text format     Abstract available

  26. ANDERSON CM, Lee CM, Saunders DP, Curtis A, et al
    Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer.
    J Clin Oncol. 2019 Oct 16:JCO1901507. doi: 10.1200/JCO.19.01507.
    PubMed     Text format     Abstract available


    Laryngoscope

  27. RANDOLPH GW, Kamani D
    In Response to letter to the editor regarding International Neuromonitoring Study Group Guidelines 2018: Part II: Optimal Recurrent Laryngeal Nerve Management for Invasive Thyroid Cancer-Incorporation of Surgical, Laryngeal, and Neural Electrophysiolo
    Laryngoscope. 2019;129:E306.
    PubMed     Text format    

  28. HACIYANLI M
    In reference to International neuromonitoring study group guidelines 2018: Part II: Optimal recurrent laryngeal nerve management for invasive thyroid cancer-incorporation of surgical, laryngeal, and neural electrophysiologic data.
    Laryngoscope. 2019;129:E305.
    PubMed     Text format    


    Otolaryngol Head Neck Surg

  29. NILSEN ML, Lyu L, Belsky MA, Mady LJ, et al
    Impact of Neck Disability on Health-Related Quality of Life among Head and Neck Cancer Survivors.
    Otolaryngol Head Neck Surg. 2019 Oct 15:194599819883295.
    PubMed     Text format     Abstract available


    Surgery

  30. GRAY KD, Bannani S, Caillard C, Amanat S, et al
    High-dose radioactive iodine therapy is associated with decreased risk of recurrence in high-risk papillary thyroid cancer.
    Surgery. 2018 Sep 28. pii: S0039-6060(18)30486.
    PubMed     Text format     Abstract available

  31. EL LAKIS M, Giannakou A, Nockel PJ, Wiseman D, et al
    Do patients with familial nonmedullary thyroid cancer present with more aggressive disease? Implications for initial surgical treatment.
    Surgery. 2018 Oct 13. pii: S0039-6060(18)30509.
    PubMed     Text format     Abstract available

  32. MARCADIS AR, Valderrabano P, Ho AS, Tepe J, et al
    Interinstitutional variation in predictive value of the ThyroSeq v2 genomic classifier for cytologically indeterminate thyroid nodules.
    Surgery. 2018 Oct 22. pii: S0039-6060(18)30502.
    PubMed     Text format     Abstract available

  33. YAN H, Hunter E, Akoulitchev A, Park P, et al
    Epigenetic chromatin conformation changes in peripheral blood can detect thyroid cancer.
    Surgery. 2018 Oct 27. pii: S0039-6060(18)30622.
    PubMed     Text format     Abstract available

  34. FISHER SB, Cote GJ, Bui-Griffith JH, Lu W, et al
    Genetic characterization of medullary thyroid cancer in childhood survivors of the Chernobyl accident.
    Surgery. 2018 Nov 1. pii: S0039-6060(18)30570-1. doi: 10.1016/j.surg.2018.
    PubMed     Text format     Abstract available

  35. LANG BHH, Wong CKH, Ma EPM, Woo YC, et al
    A propensity-matched analysis of clinical outcomes between open thyroid lobectomy and high-intensity focused ultrasound (HIFU) ablation of benign thyroid nodules.
    Surgery. 2018 Nov 1. pii: S0039-6060(18)30617-2. doi: 10.1016/j.surg.2018.
    PubMed     Text format     Abstract available

  36. MIYAUCHI A, Kudo T, Ito Y, Oda H, et al
    Natural history of papillary thyroid microcarcinoma: Kinetic analyses on tumor volume during active surveillance and before presentation.
    Surgery. 2018 Nov 6. pii: S0039-6060(18)30648-2. doi: 10.1016/j.surg.2018.
    PubMed     Text format     Abstract available

  37. SAHLI ZT, Karipineni F, Hang JF, Canner JK, et al
    The association between the ultrasonography TIRADS classification system and surgical pathology among indeterminate thyroid nodules.
    Surgery. 2018 Nov 8. pii: S0039-6060(18)30629-9. doi: 10.1016/j.surg.2018.
    PubMed     Text format     Abstract available

  38. DE RIENZO-MADERO B, Sabra JP, Gand E, Donatini G, et al
    Unilateral benign multinodular versus solitary goiter: Long-term contralateral reoperation rates after lobectomy.
    Surgery. 2018 Nov 8. pii: S0039-6060(18)30571-3. doi: 10.1016/j.surg.2018.
    PubMed     Text format     Abstract available

  39. SHAHA AR, Migliacci JC, Nixon IJ, Wang LY, et al
    Stage migration with the new American Joint Committee on Cancer (AJCC) staging system (8th edition) for differentiated thyroid cancer.
    Surgery. 2018 Nov 8. pii: S0039-6060(18)30578-6. doi: 10.1016/j.surg.2018.
    PubMed     Text format     Abstract available

  40. CARMONA MATOS DM, Jang S, Hijaz B, Chang AW, et al
    Characterization of somatostatin receptors (SSTRs) expression and antiproliferative effect of somatostatin analogues in aggressive thyroid cancers.
    Surgery. 2018 Nov 8. pii: S0039-6060(18)30569-5. doi: 10.1016/j.surg.2018.
    PubMed     Text format     Abstract available

  41. CHEREAU N, Greilsamer T, Mirallie E, Sadowski SM, et al
    NIFT-P: Are they indolent tumors? Results of a multi-institutional study.
    Surgery. 2019;165:12-16.
    PubMed     Text format     Abstract available

  42. ISHIDA T, Makino T, Yamasaki M, Tanaka K, et al
    Impact of measurement of skeletal muscle mass on clinical outcomes in patients with esophageal cancer undergoing esophagectomy after neoadjuvant chemotherapy.
    Surgery. 2019 Oct 10. pii: S0039-6060(19)30582.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: